Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 7, 2002, Pages 945-950

  Wu, J ^a   Yoon, S H ^a,b   Wu, W M ^a   Bodor, N ^a,c  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b Ajou University   (South Korea)

^c IVAX Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROTRIGONELLYL PROLYLPROLYLGLUTAMYLNORVALYLPROLYLGLYCINE O CHOLESTEROL; 2 LEUCINE DERIVATIVE; AMIDE; BARBITURIC ACID; CHOLESTEROL ESTER; DIHYDROTRIGONELLYL PROLYLPROLYLGLUTAMYLLEUCYLPROLYLGLYCINE O CHOLESTEROL; DIHYDROTRIGONELLYL PROLYLPROLYLGLUTAMYLNORVALYLPROLYLGLYCINE HYDROXIDE; GLUTAMYLNORVALYLPROLINE AMIDE; NICOTINOYL PROLYLPROLYLGLUTAMYLNORVALYLPROLYLGLYCINE HYDROXIDE; NICOTINOYL PROLYLPROLYLGLUTAMYLNORVALYLPROLYLGLYCINE O CHOLESTEROL; NORVALINE PROTIRELIN; PEPTIDE DERIVATIVE; PROTIRELIN DERIVATIVE; PYRIDINIUM NORVALYLPROLINE AMIDE; PYRIDINIUM NORVALYLPROLYLGLYCINE HYDROXIDE; PYRIDINIUM NORVALYLPROLYLGLYCINE O CHOLESTEROL; PYRRIDINIUM HISTIDYLPROLINE AMIDE; TRIGONELLYL PROLYLPROLYLGLUTAMYLNORVALYLPROLYLGLYCINE HYDROXIDE; TRIGONELLYL PROLYLPROLYLGLUTAMYLNORVALYLPROLYLGLYCINE O CHOLESTEROL; UNCLASSIFIED DRUG; AMINO ACID; DRUG DERIVATIVE; HYPNOTIC SEDATIVE AGENT; NORVALINE; PHENOBARBITAL; PROTIRELIN; VALINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG METABOLISM; DRUG SYNTHESIS; DRUG TARGETING; HYDROLYSIS; INHIBITION KINETICS; MOUSE; NONHUMAN; SLEEP TIME; ANIMAL; BLOOD BRAIN BARRIER; CHEMISTRY; SLEEP;

AMINO ACIDS; ANIMAL; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; MICE; PHENOBARBITAL; PROTIRELIN; SEDATIVES, BARBITURATE; SLEEP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VALINE; ANIMALS; HYPNOTICS AND SEDATIVES; THYROTROPIN-RELEASING HORMONE;

EID: 0035990561     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702760089063     Document Type: Article

References (24)

1. Central administration of thyrotropin-releasing hormone and histidyl-proline-diketopiperazine disrupts the acquisition of a food rewarded task by a non-aversive action
2. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans
3. Drug targeting and retrometabolic drug design approaches - Introduction
4. A strategy for delivering peptides into the central nervous system by sequential metabolism
5. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide
6. Thyrotropin-releasing hormone in specific nuclei of rat brain
7. Strategies to target kyotorphin analogues to the brain
8. Thyrotropin-releasing hormone and central nervous system trauma
9. TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats
10. Formation of the COOH-terminal amide group of thyrotropin-releasing-factor
11. Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: Regional differences and its sites of action
12. Regulatory peptides as a source of new drugs - The clinical prospects for analogues of TRH which are resistant to metabolic degradation
13. Chemical delivery system to transport a pyroglutamyl peptide amide to the central-nervous-system
14. Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue
15. Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design
16. Effects of MK-771, a TRH analog, on pentobarbital-induced alterations of cholinergic parameters in discrete regions of rat-brain
17. Effects of thyrotropine releasing hormone (TRH) on pentobarbital-induced decrease in cholinergic neuronal activity
18. Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease
19. Synthesis of thyrotropin-releasing hormone analogues. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity
20. Induction of wetdog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH)
21. Effects of a new TRH analogue, YM-14673 on the central nervous system
22. Thyrotropin releasing hormone and CNS cholinergic neurons
23. Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: Synthesis and biological evaluation
24. Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone